Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04TLJ
|
||||
Former ID |
DIB010149
|
||||
Drug Name |
Soblidotin
|
||||
Synonyms |
Auristatin PE; Dolastatin derivative; TZT-1027; YHI-501; ZT-1027
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 2 | [521565] | ||
Company |
Teikoku Hormone Manufacturing Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C39H67N5O6
|
||||
Canonical SMILES |
C(=O)(N([C@H]([C@@H](CC(=O)N1[C@H]([C@@H]([C@H](C(=O)NC<br />Cc2ccccc2)C)OC)CCC1)OC)[C@H](CC)C)C)[C@@H](NC(=O)[C@@H]<br />(N(C)C)C(C)C)C(C)C
|
||||
CAS Number |
CAS 149606-27-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin | Target Info | Modulator | [528298] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.